- Home
- / THOMSON MEDICAL GROUP
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
THOMSON MEDICAL GROUP financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$1.3 B
2024-10-29
Revenue
$394.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SGD | FY, 2018 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 311.6M | 334.8M | 240.4M | 333.7M | 355.8M | 351.2M | 394.7M |
| Cost of goods sold | 44.7M | 70.3M | 49.5M | 55.3M | 59.4M | 75.8M | 99.3M |
| Gross profit | 292.0M | 278.6M | 202.8M | 288.2M | 302.0M | 306.9M | 356.2M |
| Gross profit margin, % | 83.2% | 84.9% | 87.4% | 90.3% | |||
| Operating expense total | 247.7M | 298.8M | 135.9M | 178.3M | 198.6M | 204.9M | 226.3M |
| Depreciation and amortization | 17.5M | 26.4M | 18.0M | 18.1M | 21.1M | 28.4M | 113.8M |
| EBITDA | 45.3M | (20.3M) | 67.0M | 109.9M | 103.0M | 101.8M | 129.4M |
| EBITDA margin, % | -6.1% | 28.9% | 29.0% | 32.8% | |||
| EBIT | 27.8M | (46.7M) | 49.0M | 91.8M | 81.9M | 73.4M | 15.6M |
| EBIT margin, % | -13.9% | 23.0% | 20.9% | 3.9% | |||
| Interest income | 3.1M | 3.9M | 980.0K | 988.0K | 3.9M | 7.4M | 3.6M |
| Interest expense | 19.0M | 38.1M | 23.6M | 23.5M | 30.5M | 51.6M | 59.7M |
| Pre tax profit | 11.8M | (81.7M) | 26.2M | 69.3M | 55.2M | 29.2M | (40.6M) |
| Income tax expense | 7.8M | 14.4M | 9.3M | 10.7M | 14.1M | 10.9M | 6.4M |
| Net Income | 4.1M | (96.2M) | 16.9M | 58.6M | 41.1M | 18.2M | (47.0M) |